Skip to content
Andrew Charrette
Director of Regulatory Affairs

Leading the regulatory affairs division of KGK Science, Andrew Charette brings extensive experience in regulatory processes for clinical trial research and in-depth knowledge of the cannabis regulations in North America. Since joining KGK in 2013, Andrew has led over 50 submissions to Health Canada and consulted on numerous product claims, NDI notifications and GRAS submissions to the U.S. FDA. Andrew received his undergraduate degree in Pharmacology and Physiology from the University of Western Ontario and later obtained a Master’s degree in Neuroscience from the University of Ottawa.

google-site-verification=ODzIjcIVmduDgyhTx98JdCy2M5Br0YEsotjjaj0hZbI